Type 2 diabetes mellitus: The grand overview

Diabetic Medicine

Volumn 15, Issue SUPPL. 4, 1998, Pages

  Ratner, Robert E ^a  

^a Medlantic Research Institute   (United States)

Author keywords

Implantable insulin infusion systems; Insulin therapy; Pancreas transplantation; Prevention strategies; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; ANTIDIABETIC AGENT; GLUCOSE; INSULIN;

BUDGET; DIABETES CONTROL; DIABETIC RETINOPATHY; DIET THERAPY; GLUCOSE INTOLERANCE; HEALTH CARE COST; HOME MONITORING; HUMAN; INSULIN INFUSION; MEDICARE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS TRANSPLANTATION; REVIEW;

AGED; CANADA; DIABETES MELLITUS, TYPE 2; EUROPE; GLUCOSE INTOLERANCE; HUMANS; LIFE STYLE; MEDICARE; MORBIDITY; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIALS; UNITED STATES;

EID: 0031765670     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9136(1998120)15:4+3.3.co;2-t     Document Type: Article

References (14)

1. Rubin RJ, Altman WM, Mendelson DN. Healthcare expenditures for people with diabetes mellitus. J Clin Endocrinol Metab 1994; 78: 809a-809f.
2. Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of non-insulin dependent diabetes. In: Diabetes in America. NIH Publication #95-1468; 1995: 47-67.
3. Dornhurst A, Rossi M. Risk and prevention of type 2 diabetes in women with gestational diabetes. Diabetes Care 1998; 21 (Suppl 2): B43-B49.
4. Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired glucose tolerance to NIDDM. Diabetes 1997; 46: 701-710.
5. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544.
6. Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC. UKPDS 26: Sulfonylurea failure in non-insulin dependent diabetic patients over 6 years. UK Prospective Diabetes Study Group. Diabet Med 1998; 15: 297-303.
7. Cough DA, Armour JC. Development of the implantable glucose sensor: what are the prospects and why is it taking so long? Diabetes 1995; 44: 1005-1009.
8. Saudek CD, Duckworth WC, Henry RR, et al. Implantable insulin pump vs multiple-dose insulin in NIDDM. JAMA 1996; 276: 1322-1327.
9. American Diabetes Association. Position statement: pancreas transplantation for patients with diabetes mellitus. Diabetes Care 1998; 21 (Suppl 1): S79.
10. Sasaki TM, Gray RS, Ratner RE, Currier C, Aquino A, Barhyte DY, Light JA. Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels. Transplantation 1998; 65: 1510-1512.
11. Weir GC, Bonner-Weir S. Scientific and political impediments to successful islet transplantation. Diabetes 1997; 46: 1247-1256.
12. Faustman D, Coe C. Prevention of xenograft rejection by masking donor HLA class I antigens. Science 1991; 252: 1700-1702.
13. Hughes SD, Johnson JH, Quaade C, Newgard CB. Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells. Proc Natl Acad Sci 1992; 89: 688-692.
14. Docherty K. Gene therapy for diabetes mellitus. Clin Sci 1997; 92: 321-330.